These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 36442624)
1. Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease. Ren Y; Zhu X; Fu K; Zhang H; Zhao W; Lin Y; Fang Q; Wang J; Chen Y; Guo D Biochem Pharmacol; 2023 Jan; 207():115355. PubMed ID: 36442624 [TBL] [Abstract][Full Text] [Related]
2. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease. Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431 [TBL] [Abstract][Full Text] [Related]
3. Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease. Onori P; Mancinelli R; Franchitto A; Carpino G; Renzi A; Brozzetti S; Venter J; Francis H; Glaser S; Jefferson DM; Alpini G; Gaudio E Liver Int; 2013 Jul; 33(6):914-25. PubMed ID: 23617956 [TBL] [Abstract][Full Text] [Related]
4. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Lanoix J; D'Agati V; Szabolcs M; Trudel M Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689 [TBL] [Abstract][Full Text] [Related]
5. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression. Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180 [TBL] [Abstract][Full Text] [Related]
6. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD). Nikonova AS; Deneka AY; Kiseleva AA; Korobeynikov V; Gaponova A; Serebriiskii IG; Kopp MC; Hensley HH; Seeger-Nukpezah TN; Somlo S; Proia DA; Golemis EA FASEB J; 2018 May; 32(5):2735-2746. PubMed ID: 29401581 [TBL] [Abstract][Full Text] [Related]
7. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Takakura A; Nelson EA; Haque N; Humphreys BD; Zandi-Nejad K; Frank DA; Zhou J Hum Mol Genet; 2011 Nov; 20(21):4143-54. PubMed ID: 21821671 [TBL] [Abstract][Full Text] [Related]
8. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461 [TBL] [Abstract][Full Text] [Related]
9. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis. He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678 [TBL] [Abstract][Full Text] [Related]
10. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease. Kurbegovic A; Trudel M Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315 [TBL] [Abstract][Full Text] [Related]
12. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage. Jin C; Einig E; Xu W; Kollampally RB; Schlosser A; Flentje M; Popov N Nucleic Acids Res; 2024 Apr; 52(6):3011-3030. PubMed ID: 38227944 [TBL] [Abstract][Full Text] [Related]
13. The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells. Li J; Peng J; Wu L; Shen X; Zhen X; Zhang Y; Ma H; Xu Y; Xiong Q; Zhu Q; Zhang P J Biol Chem; 2023 Jul; 299(7):104856. PubMed ID: 37230388 [TBL] [Abstract][Full Text] [Related]
14. Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis. Patera F; Cudzich-Madry A; Huang Z; Fragiadaki M Sci Rep; 2019 Mar; 9(1):4491. PubMed ID: 30872773 [TBL] [Abstract][Full Text] [Related]
15. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. Zhou X; Fan LX; Sweeney WE; Denu JM; Avner ED; Li X J Clin Invest; 2013 Jul; 123(7):3084-98. PubMed ID: 23778143 [TBL] [Abstract][Full Text] [Related]
16. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer. Diefenbacher ME; Popov N; Blake SM; Schülein-Völk C; Nye E; Spencer-Dene B; Jaenicke LA; Eilers M; Behrens A J Clin Invest; 2014 Aug; 124(8):3407-18. PubMed ID: 24960159 [TBL] [Abstract][Full Text] [Related]
17. c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis. Parrot C; Kurbegovic A; Yao G; Couillard M; Côté O; Trudel M Hum Mol Genet; 2019 Mar; 28(5):751-763. PubMed ID: 30388220 [TBL] [Abstract][Full Text] [Related]
18. Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease. Sun Y; Liu Z; Cao X; Lu Y; Mi Z; He C; Liu J; Zheng Z; Li MJ; Li T; Xu D; Wu M; Cao Y; Li Y; Yang B; Mei C; Zhang L; Chen Y Sci Adv; 2019 Jun; 5(6):eaaw3593. PubMed ID: 31183407 [TBL] [Abstract][Full Text] [Related]
19. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310 [TBL] [Abstract][Full Text] [Related]
20. Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease. Kenter AT; van Rossum-Fikkert SE; Salih M; Verhagen PCMS; van Leenders GJLH; Demmers JAA; Jansen G; Gribnau J; Zietse R; Hoorn EJ Am J Physiol Renal Physiol; 2019 Jan; 316(1):F204-F213. PubMed ID: 30403162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]